Insulin-like factor 3 and the HPG axis in the male

Frontiers in Endocrinology

Volumn 5, Issue JAN, 2014, Pages

  Ivell, Richard ^a,b   Heng, Kee ^a   Anand Ivell, Ravinder ^c  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b LEIBNIZ INSTITUTE FOR FARM ANIMAL BIOLOGY FBN   (Germany)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Hypothalamic hypogonadism; INSL3; Leydig cell; Puberty; RXFP2; Testosterone

Indexed keywords

GONADOTROPIN; SOMATOMEDIN BINDING PROTEIN 3;

CELL DIFFERENTIATION; ENZYME ACTIVITY; HUMAN; HYPOGONADISM; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MICROARRAY ANALYSIS; NONHUMAN; PROTEIN EXPRESSION; PUBERTY; REVIEW; SPERMATOGENESIS; STEROIDOGENESIS;

EID: 84898410154     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2014.00006     Document Type: Review

References (51)

1. Bathgate RA, Hsueh AJ, Ivell R, Sanborn BM, Sherwood OD, Summers RJ. International Union of Pharmacology. Recommendations for the nomenclature of receptors for relaxin family peptides. Pharmacol Rev (2006) 58:7-31. doi:10.1124/pr.58.1.9
2. Ivell R, Kotula-Balak M, Glynn D, Heng K, Anand-Ivell R. Relaxin family peptides in the male reproductive system - a critical appraisal. Mol Hum Reprod (2011) 17:71-84. doi:10.1093/molehr/gaq086
3. Bullesbach EE, Schwabe C. The primary structure and disulfide links of the bovine relaxin-like factor (RLF). Biochemistry (2002) 41:274-81. doi:10.1021/bi0117302
4. Minagawa I, Fukuda M, Ishige H, Kohriki H, Shibata M, Park EY, et al. Relaxin-like factor (RLF)insulin-like peptide 3 (INSL3) is secreted from testicular Leydig cells as a monomeric protein comprising three domains B-C-A with full biological activity in boars. Biochem J (2012) 441:265-73. doi:10.1042/BJ20111107
5. Siqin, Minagawa I, Okuno M, Yamada K, Sugawara Y, Nagura Y, et al. The active form of goat insulin-like peptide 3 (INSL3) is a single-chain structure comprising three domains B-C-A, constitutively expressed and secreted by testicular Leydig cells. Biol Chem (2013) 394:1181-94. doi:10.1515/hsz-2012-0357
6. Ivell R, Wade JD, Anand-Ivell R. Insulin-like factor 3 (INSL3) as a biomarker of Leydig cell functional capacity. Biol Reprod (2013) 88:147. doi:10.1095/biolreprod.113.108969
7. Foresta C, Bettella A, Vinanzi C, Dabrilli P, Meriggiola MC, Garolla A, et al. A novel circulating hormone of testis origin in humans. J Clin Endocrinol Metab (2004) 89:5952-8. doi:10.1210/jc.2004-0575
8. Bay K, Hartung S, Ivell R, Schumacher M, Jurgensen D, Jorgensen N, et al. Insulin-like factor 3 serum levels in 135 normal men and 85 men with testicular disorders: relationship to the luteinizing hormone-testosterone axis. J Clin Endocrinol Metab (2005) 90:3410-8. doi:10.1210/jc.2004-2257
9. Anand-Ivell RJK, Wohlgemuth J, Haren MT, Hope PJ, Hatzinikolas G, Wittert G, et al. Peripheral INSL3 concentrations decline with age in a large population of Australian men. Int J Androl (2006) 29:618-26. doi:10.1111/j.1365-2605.2006.00714.x
10. Anand-Ivell R, Heng K, Hafen B, Setchell B, Ivell R. Dynamics of INSL3 peptide expression in the rodent testis. Biol Reprod (2009) 81:480-7. doi:10.1095/biolreprod.109.077552
11. Kawate N, Ohnari A, Pathirana IN, Büllesbach EE, Takahashi M, Inaba T, et al. Changes in plasma concentrations of insulin-like peptide 3 and testosterone from birth to pubertal age in beef bulls. Theriogenology (2011) 76:1632-8. doi:10.1016/j.theriogenology.2011.07.011
12. Anand-Ivell R, Ivell R. INSL3 as a monitor of endocrine disruption. Reproduction (2013). doi:10.1530/REP-13-0486.
13. O'Shaugnessy PJ, Fleming LM, Jackson G, Hochgeschwender U, Reed P, Baker PJ. Adrenocorticotropic hormone directly stimulates testosterone production by the fetal and neonatal mouse testis. Endocrinology (2003) 144:3279-84. doi:10.1210/en.2003-0277
14. O'Shaugnessy PJ, Baker P, Sohnius U, Haavisto AM, Charlton HM, Huhtaniemi I. Fetal development of Leydig cell activity in the mouse is independent of pituitary gonadotroph function. Endocrinology (1998) 139:1141-6. doi:10.1210/en.139.3.1141
15. Balvers M, Spiess AN, Domagalski R, Hunt N, Kilic E, Mukhopadhyay AK, et al. Relaxin-like factor expression as a marker of differentiation in the mouse testis and ovary. Endocrinology (1998) 139:2960-70. doi:10.1210/endo.139.6.6046
16. Kubota Y, Temelcos C, Bathgate RA, Smith KJ, Scott D, Zhao C, et al. The role of insulin 3, testosterone, Müllerian inhibiting substance and relaxin in rat gubernacular growth. Mol Hum Reprod (2002) 8:900-5. doi:10.1093/molehr/8.10.900
17. Yuan FP, Li X, Lin J, Schwabe C, Büllesbach EE, Rao CV, et al. The role of RXFP2 in mediating androgen-induced inguinoscrotal testis descent in LH receptor knockout mice. Reproduction (2010) 139:759-69. doi:10.1530/REP-09-0518
18. Glister C, Satchell L, Bathgate RA, Wade JD, Dai Y, Ivell R, et al. A functional link between bone morphogenetic protein and insulin-like peptide 3 signaling in modulating ovarian androgen production. Proc Natl Acad Sci U S A (2013) 110:E1426-35. doi:10.1073/pnas.1222216110
19. Barthold JS, Wang Y, Robbins A, Pike J, McDowell E, Johnson KJ, et al. Transcriptome analysis of the dihydrotestosterone-exposed fetal rat gubernaculum identifies common androgen and insulin-like 3 targets. Biol Reprod (2013) 89:143. doi:10.1095/biolreprod.113.112953
20. Hutson JM, Southwell BR, Li R, Lie G, Ismail K, Harisis G, et al. The regulation of testicular descent and the effects of cryptorchidism. Endocr Rev (2013) 34:725-52. doi:10.1210/er.2012-1089
21. Hadziselimovic F, Zivkovic D, Bica DT, Emmons LR. The importance of mini-puberty for fertility in cryptorchidism. J Urol (2005) 174:1536-9. doi:10.1097/01.ju.0000181506.97839.b0
22. Veldhuizen Tsoerkan MB, Ivell R, Teerds K. Human chorionic gonadotrophin (hCG) induced changes in luteinizing hormone/hCG receptor messenger ribonucleic acid transcript levels in the testis of adult, hypophysectomized, ethane dimethyl sulphonate treated rats. Mol Cell Endocrinol (1994) 105:37-44. doi:10.1016/0303-7207(94)90033-7
23. Zhang FP, Hämäläinen T, Kaipia A, Pakarinen P, Huhtaniemi I. Ontogeny of luteinizing hormone receptor gene expression in the rat testis. Endocrinology (1994) 134:2206-13. doi:10.1210/en.134.5.2206
24. Tena-Sempere M, Zhang FP, Huhtaniemi I. Persistent expression of a truncated form of the luteinizing hormone receptor messenger ribonucleic acid in the rat testis after selective Leydig cell destruction by ethylene dimethane sulfonate. Endocrinology (1994) 135:1018-24. doi:10.1210/endo.135.3.8070344
25. Wennink JM, Delemarre-van de Waal HA, Schoemaker R, Schomaker H, Schoemaker J. Luteinizing hormone and follicle stimulating hormone secretion patterns in boys throughout puberty measured using highly sensitive immunoradiometric assays. Clin Endocrinol (1989) 31:551-64. doi:10.1111/j.1365-2265.1989.tb01279.x
26. Sharpe RM, Doogan DG, Cooper I. Intratesticular factors and testosterone secretion: the role of luteinizing hormone in relation to changes during puberty and experimental cryptorchidism. Endocrinology (1986) 119:2089-96. doi:10.1210/endo-119-5-2089
27. Bartlett JMS, Charlton HM, Robinson ICAF, Nieschlag E. Pubertal development and testicular function in the male growth hormone-deficient rat. J Endocrinol (1990) 126:193-201. doi:10.1677/joe.0.1260193
28. Sadeghian H, Anand-Ivell R, Balvers M, Relan V, Ivell R. Constitutive regulation of the INSL3 gene in rat Leydig cells. Mol Cell Endocrinol (2005) 124:10-20. doi:10.1016/j.mce.2005.03.017
29. Trabado S, Maione L, Bry-Gauillard H, Affres H, Salenave S, Sarfati J, et al. Insulin-like peptide 3 (INSL3) in men with congenital hypogonadotropic hypogonadism/Kallmann syndrome and effects of different modalities of hormonal treatment: a single-center study of 281 patients. J Clin Endocrinol Metab (2013). doi:10.1210/jc.2013-2288.
30. Andersson AM, Jorgensen N, Frydelund-Larsen L, Rajpert-De Meyts E, Skakkebaek NE. Impaired Leydig cell function in infertile men: a study of 357 idiopathic infertile men and 318 proven fertile controls. J Clin Endocrinol Metab (2006) 89:3161-7. doi:10.1210/jc.2003-031786
31. De Kretser DM. Editorial: is spermatogenic damage associated with Leydig cell dysfunction? J Clin Endocrinol Metab (2006) 89:3158-60. doi:10.1210/jc.2004-0741
32. Diver MJ. Analytical and physiological factors affecting the interpretation of serum testosterone concentration in men. Ann Clin Biochem (2006) 43:3-12. doi:10.1258/000456306775141803
33. Ivell R, Anand-Ivell R. The biology of Insulin-like Factor 3 (INSL3) in human reproduction. Hum Reprod Update (2009) 15:463-76. doi:10.1093/humupd/dmp011
34. Johansen ML, Anand-Ivell R, Mouritsen A, Hagen CP, Mieritz MG, Soeborg T, et al. Serum levels of insulin-like factor 3, anti-Mullerian hormone, inhibin B and testosterone during pubertal transition in healthy boys: a longitudinal study. Reproduction (in press).
35. Nef S, Parada LF. Cryptorchidism in mice mutant for Insl3. Nat Genet (1999) 22:295-9. doi:10.1038/10364
36. Zimmermann S, Steding G, Emmen JM, Brinkmann AO, Nayernia K, Holstein AF, et al. Targeted disruption of the Insl3 gene causes bilateral cryptorchidism. Mol Endocrinol (1999) 13:681-91. doi:10.1210/me.13.5.681
37. Ferlin A, Pepe A, Gianesello L, Garolla A, Feng S, Giannini S, et al. Mutations in the insulin-like factor 3 receptor are associated with osteoporosis. J Bone Miner Res (2008) 23:683-93. doi:10.1359/jbmr.080204
38. Johnston SE, Gratten J, Berenos C, Pilkinmgton JG, Clutton-Brock TH, Pemberton JM, et al. Life history trade-offs at a single locus maintain sexually selected genetic variation. Nature (2013) 502:93-5. doi:10.1038/nature12489
39. Anand-Ivell RJK, Relan V, Balvers M, Fritsch M, Bathgate RAD, Ivell R. Expression of the Insulin-like peptide 3 (INSL3) hormone-receptor (LGR8) system in the testis. Biol Reprod (2006) 74:945-53. doi:10.1095/biolreprod.105.048165
40. Kawamura K, Kumagai J, Sudo S, Chun S-Y, Pisarska M, Morita H, et al. Paracrine regulation of oocyte maturation and male germ cell survival. Proc Natl Acad Sci U S A (2004) 101:7323-8. doi:10.1073/pnas.0307061101
41. Filonzi M, Cardoso LC, Pimenta MT, Queiroz DB, Avellar MC, Porto CS, et al. Relaxin family peptide receptors Rxfp1 and Rxfp2: mapping of the mRNA and protein distribution in the reproductive tract of the male rat. Reprod Biol Endocrinol (2007) 5:29. doi:10.1186/1477-7827-5-29
42. Pathirana IN, Kawate N, Büllesbach EE, Takahashi M, Hatoya S, Inaba T, et al. Insulin-like peptide 3 stimulates testosterone secretion in mouse Leydig cells via cAMP pathway. Regul Pept (2012) 178:102-6. doi:10.1016/j.regpep.2012.07.003
43. Del Borgo MP, Hughes RA, Bathgate RA, Lin F, Kawamura K, Wade JD. Analogs of insulin-like peptide (INSL3) B-chain are LGR8 antagonists in vitro and in vivo. J Biol Chem (2006) 281:13068-74. doi:10.1074/jbc.M600472200
44. Amory JK, Page ST, Anawalt BD, Coviello AD, Matsumoto AM, Bremner WJ. Elevated end-of-treatment serum INSL3 is associated with failure to completely suppress spermatogenesis in men receiving male hormone contraception. J Androl (2007) 28:548-54. doi:10.2164/jandrol.106.002345
45. Ivell R, Bathgate RAD. Hypothesis: neohormone systems as exciting targets for drug development. Trends Endocrinol Metab (2006) 17:123. doi:10.1016/j.tem.2006.03.004
46. Anand-Ivell R, Dai Y, Ivell R. Neohormones as biomarkers of reproductive health. Fertil Steril (2013) 99:1153-60. doi:10.1016/j.fertnstert.2012.12.023
47. Xue K, Kim JY, Liu JY, Tsang BK. Insulin-like 3 induced rat preantral follicular growth is mediated by growth differentiation factor 9. Endocrinology (2014) 155:156-67. doi:10.1210/en.2013-1491
48. Spanel-Borowski K, Schäfer I, Zimmermann S, Engel W, Adham IM. Increase in final stages of follicular atresia and premature decay of corpora lutea in Insl3-deficient mice. Mol Reprod Dev (2001) 58:281-6. doi:10.1002/1098-2795(200103)58:3<281::AID-MRD6>3.0.CO;2-0
49. Huang Z, Rivas B, Agoulnik AI. Insulin-like 3 signaling is important for testicular descent but dispensable for spermatogenesis and germ cell survival in adult mice. Biol Reprod (2012) 87:143. doi:10.1095/biolreprod.112.103382
50. Chen H, Hardy MP, Huhtaniemi I, Zirkin BR. Age-related decreased Leydig cell testosterone production in the brown Norway rat. J Androl (1994) 15:551-7.
51. Neaves WB, Johnson L, Porter JC, Parker CR, Petty CS. Leydig cell numbers, daily sperm production and serum gonadotropin levels in aging men. J Clin Endocrinol Metab (1984) 59:756-63. doi:10.1210/jcem-59-4-756